Pharmaceutical Technology14 小时
PSP-001 by Prosit Sole Biotechnology (Beijing) for Norovirus Infections: Likelihood of Approval
PSP-001 is under clinical development by Prosit Sole Biotechnology (Beijing) and currently in Phase I for Norovirus Infections.